IVA
Inventiva Sa
NASDAQ: IVA · HEALTHCARE · BIOTECHNOLOGY
$5.13
+3.85% today
Updated 2026-04-30
Market cap
$1.07B
P/E ratio
—
P/S ratio
157.56x
EPS (TTM)
$-2.23
Dividend yield
—
52W range
$3 – $8
Volume
0.4M
Inventiva Sa (IVA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.01M | $-14.79M | $-13.98M | $-14.86M | $-17.00M | $-34.21M | $-28.40M | $-30.59M | $-47.63M | $-44.93M | $-81.61M | $-85.93M | $-100.98M |
| Capital expenditures | $1.92M | $1.29M | $968990.00 | $227937.00 | $428029.00 | $549000.00 | $136000.00 | $292000.00 | $534000.00 | $561000.00 | $540000.00 | $333000.00 | $237255.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2217.00 | $44950.00 | $67460.00 | $3.10M | $683606.00 | $833000.00 | $1.41M | $938000.00 | $2.09M | $2.22M | $3.97M | $3.58M | $26.77M |
| Free cash flow | $-17.93M | $-16.08M | $-14.95M | $-15.09M | $-17.43M | $-34.76M | $-28.54M | $-30.88M | $-48.16M | $-45.49M | $-82.15M | $-86.26M | $-101.22M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — |